Our analyses of clinical gliomas reveal a close correlation between co-expression of TRIM24/p-EGFR, TRIM24/H3K23ac and TRIM24/p-STAT3 with poor prognoses in GBM patients. This evidence concerns the gene EGFR and central nervous system cancer.